PYRAZOLOPYRIMIDINES AS INHIBITORS OF PROTEIN KINASE B (AKT)
申请人:Bayer Schering Pharma Aktiengesellschaft
公开号:EP1797096B1
公开(公告)日:2011-07-27
US7745446B2
申请人:——
公开号:US7745446B2
公开(公告)日:2010-06-29
Novel Pyrazolopyrimidines
申请人:Maier Thomas
公开号:US20070254046A1
公开(公告)日:2007-11-01
Compounds of a certain formula I
in which R1, R2, R3 and R4 have the meanings indicated in the description are novel compounds expected to be useful in the therapy of (hyper)proliferative diseases and/or disorders responsive to induction of apoptosis.